Shield Therapeutics reports positive results in paediatric trial
1st Oct 2025 13:31
(Alliance News) - Shield Therapeutics PLC on Wednesday noted positive efficacy and tolerance results from in its phase three ferric maltol Fortis trial. Read More
| Price | 8.15p on 10-10-2025 at 13:55:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 8.30p |
| Sell | 8.00p |
| Last Trade: | Sell 2,500.00 at 8.00p |
| Day's Volume: | 980,663 |
| Last Close: | 8.15p |
| Open: | 8.15p |
| ISIN: | GB00BYV81293 |
| Day's Range | 8.00p - 8.15p |
| 52wk Range: | 2.20p - 9.00p |
| Market Capitalisation: | £86.54m |
| VWAP: | 8.178403p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 2,500 | 8.00p | Uncrossing Trade |
14:00:16 - 10-Oct-25 |
| Buy* | 5,690 | 8.19p | Ordinary |
13:51:49 - 10-Oct-25 |
| Buy* | 70 | 8.225p | Ordinary |
13:42:16 - 10-Oct-25 |
| Buy* | 121 | 8.225p | Ordinary |
13:37:07 - 10-Oct-25 |
| Sell* | 50,000 | 8.031p | Ordinary |
12:52:59 - 10-Oct-25 |
| Sell* | 50,000 | 8.11p | Ordinary |
12:43:02 - 10-Oct-25 |
| Buy* | 6,048 | 8.20p | Ordinary |
12:20:32 - 10-Oct-25 |
| Sell* | 38,153 | 8.11p | Ordinary |
12:12:29 - 10-Oct-25 |
| Buy* | 4,819 | 8.30p | SI Trade |
11:25:29 - 10-Oct-25 |
| Buy* | 11,445 | 8.30p | SI Trade |
11:25:29 - 10-Oct-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
| 3rd Sep 2025 2:17 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 27th Aug 2025 7:13 am | RNS | Data published -European Journal of Heart Failure |
| 21st Aug 2025 12:06 pm | RNS | Interim results for the six months ended 30 Jun 25 |
| 23rd Jul 2025 7:00 am | RNS | Q2 2025 Trading Update |
| 22nd May 2025 5:06 pm | RNS | Result of AGM |
| 24th Apr 2025 7:06 am | RNS | Audited results for the year ended 31 Dec 2024 |